Icariin-Ieariline-DataSheet-MedChemExpress_第1页
Icariin-Ieariline-DataSheet-MedChemExpress_第2页
Icariin-Ieariline-DataSheet-MedChemExpress_第3页
Icariin-Ieariline-DataSheet-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEIcariinCat. No.: HY-N0014CAS No.: 489-32-7Synonyms: Ieariline分式: CHO分量: 676.66作靶点: Phosphodiesterase (PDE); PPAR; Autophagy作通路: Metabolic Enzyme/Protease; Cell Cycle/DNA Damage;Autophagy储存式: Powder -20C 3 years4C 2 yearsIn solve

2、nt -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 34 mg/mL (50.25 mM)H2O : 40% PEG300 5% Tween-80 45% salineSolubility: 2.5 mg/mL (3.69 mM); Clear solution1/3 Master of Small Molecules 您边的抑制剂师www.MedChemE2. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.5 mg/mL (3.69 mM); Clear solutionBIOLOGICAL ACTIVITY

3、物活性 Icariin种 酮醇苷。 Icariin 抑制 PDE5 和 PDE4 活性,IC50 分别为 432 nM 和 73.50 M。Icariin 也 种 PPAR 激活剂。IC50 & Target PDE5 PDE4 PPAR Autophagy432 nM (IC50) 73.5 M (IC50)体外研究 Icariin is a cGMP-specific PDE5 inhibitor. The inhibitory effects of Icariin on PDE5 and PDE4 activities areinvestigated by the two-step ra

4、dioisotope procedure with 3H-cGMP/ 3H-cAMP. The potency of selectivity ofIcariin on PDE5 (PDE4/PDE5 of IC50) is 167.67 times 1. Cell viability is measured in the present study toevaluate whether Icariin protect endothelial HUVECs from injuries induced by oxidized low-density lipoprotein(ox-LDL). The

5、 exposure of the cells to ox-LDL for 24 h significantly decreases the cell viability compared withcontrol group (P 3.体内研究 Icariin is a PPAR activator, induces Cyp4a10 and Cyp4a14, and regulates the mRNA levels of lipidmetabolism enzymes and proteins, including fatty acid binding protein, fatty acid

6、oxidation in mitochondriaand in peroxisome. Icariin is effective in the treatment of hyperlipidemia. To understand the effect of Icariin onlipid metabolism, effects of Icariin on PPAR and its target genes are investigated. Mice are treated orallywith Icariin at doses of 0, 100, 200, and 400 mg/kg, o

7、r Clofibrate (500 mg/kg) for five days. Liver total RNA isisolated and the expressions of PPAR and lipid metabolism genes are examined. PPAR and its markergenes Cyp4a10 and Cyp4a14 are induced 2-4 fold by Icariin, and 4-8 fold by Clofibrate. The fatty acid (FA)binding and co-activator proteins Fabp1

8、, Fabp4 and Acsl1 are increased 2-fold. The mRNAs of mitochondrialFA -oxidation enzymes (Cpt1a, Acat1, Acad1 and Hmgcs2) are increased 2-3 fold. The mRNAs of proximal-oxidation enzymes (Acox1, Ech1, and Ehhadh) are also increased by Icariin and Clofibrate. The expressionof mRNAs for sterol regulator

9、y element-binding factor-1 (Srebf1) and FA synthetase (Fasn) are unaltered byIcariin. The lipid lysis genes Lipe and Pnpla2 are increased by Icariin and Clofibrate 2. Adult rats are treatedorally with Icariin at doses of 0 (control), 50, 100, or 200 mg/kg body weight for 35 consecutive days. Theresu

10、lts show that Icariin has virtually no effect on the body weight or organ coefficients of the testes orepididymides. However, 100 mg/kg Icariin significantly increases epididymal sperm counts. In addition, 50and 100 mg/kg Icariin significantly increase testosterone levels. Furthermore, 100 mg/kg Ica

11、riin treatmentalso affects follicle stimulating hormone receptor (FSHR) and claudin-11 mRNA expression in Sertoli cells.Superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels are measured in the testes; 50 and100 mg/kg Icariin treatment improve antioxidative capacity, while 200 mg/kg I

12、cariin treatment upregulatesoxidative stress 4.PROTOCOLCell Assay 3 Human umbilical vein endothelial cells (HUVECs) in the logarithmic growth phase are seeded into 96-well2/3 Master of Small Molecules 您边的抑制剂师www.MedChemEplates at a density of 1104 cells per well, then incubated for 24 hours at 37C,

13、5% CO2. After pretreatmentwith indicated concentration of Icariin (0, 10, 20, 40 M) for 24 hours, the cells are incubated with or withoutox-LDL (100 g/mL) for next 24 hours. After suction of the liquid in the wells, MTT solution is added to yield afinal concentration of 0.5 mg/mL, and incubation is

14、continued for 4 h at 37C, 5% CO2. MTT solution isremoved gently and 150 L of DMSO is added to each well for 15 min incubation. The absorbance of eachsample is measrured on a microplate reader at 490 nm as cell viability 3.MCE has not independently confirmed the accuracy of these methods. They are fo

15、r reference only.Animal Mice 2Administration 24 Adult 8-week old male C57BL/6 mice are acclimated for 1-week in a temperature- and humidity-controlledfacility with a standard 12-h light schedule. Mice have free access to SPF-grade rodent chow and purifieddrinking water. Mice are treated with Icariin

16、 (100, 200, and 400 mg/kg) for 5 days. Clofibrate (CLO, 500mg/kg, po for 5 days) is used as a positive control, for negative controls, mice are given 2% CMC (10 mL/kg).24 h after the last dose, livers are collected for analysis.Rats 4Forty adult male SD rats weighing 200-290 g (12-16 weeks old) are

17、randomly assigned to groups (n=10 pergroup) according to their body weight. The rats receive daily intragastric administration of Icariin at 0(control), 50, 100, or 200 mg/kg per day for 35 consecutive days. The animals are weighed weekly, and thetreatments are adjusted accordingly. At the end of th

18、e Icariin treatment period, all rats are sacrificed; bloodsamples are subsequently collected for further analyses of testosterone levels.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 J Cell Biochem. 2019 Mar 19.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Xin ZC, et al. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activ

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论